Figure 1From: Thiazolidinedione induced thyroid associated orbitopathyA. Patient, previous photograph prior to initiation of TZD. B. Patient, on initial visit, with evidence of eyelid retraction and severe proptosis. C. Patient, at six-week follow-up visit. D. Patient, at 3 month follow-up visit.Back to article page